Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes.

MLA

Pabel, Steffen, et al. “Long-Term Effects of Empagliflozin on Excitation-Contraction-Coupling in Human Induced Pluripotent Stem Cell Cardiomyocytes.” Journal of Molecular Medicine, vol. 98, no. 12, Dec. 2020, pp. 1689–700. EBSCOhost, https://doi.org/10.1007/s00109-020-01989-6.

APA

Pabel, S., Reetz, F., Dybkova, N., Shomroni, O., Salinas, G., Mustroph, J., Hammer, K. P., Hasenfuss, G., Hamdani, N., Maier, L. S., Streckfuss-Bömeke, K., & Sossalla, S. (2020). Long-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes. Journal of Molecular Medicine, 98(12), 1689–1700. https://doi.org/10.1007/s00109-020-01989-6

Chicago

Pabel, Steffen, Florian Reetz, Nataliya Dybkova, Orr Shomroni, Gabriela Salinas, Julian Mustroph, Karin P. Hammer, et al. 2020. “Long-Term Effects of Empagliflozin on Excitation-Contraction-Coupling in Human Induced Pluripotent Stem Cell Cardiomyocytes.” Journal of Molecular Medicine 98 (12): 1689–1700. doi:10.1007/s00109-020-01989-6.